To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Speech in Westminster Hall - Tue 02 Jul 2019
Acquired Brain Injury

"I warmly congratulate my hon. Friend not only on securing this debate, but on his fantastic campaigning work in this area. On the symptoms being invisible, Departments, particularly the Department for Work and Pensions, cannot pick up precisely how such injuries affect day-to-day life, and that needs to be improved...."
Nick Thomas-Symonds - View Speech

View all Nick Thomas-Symonds (Lab - Torfaen) contributions to the debate on: Acquired Brain Injury
Speech in Westminster Hall - Tue 29 Jan 2019
Children with Life-limiting Conditions

"I thank the hon. Gentleman for giving way and congratulate him on securing this debate. Will he join me in praising the children’s hospice movement, including Tŷ Hafan, which serves my constituency in south Wales, for their excellent work in providing care not only for the children but for the …..."
Nick Thomas-Symonds - View Speech

View all Nick Thomas-Symonds (Lab - Torfaen) contributions to the debate on: Children with Life-limiting Conditions
Speech in Commons Chamber - Thu 24 Jan 2019
Appropriate ME Treatment

"I pay tribute to the hon. Member for Glasgow North West (Carol Monaghan) for securing the debate. The Welsh Association of ME and CFS Support confirms that 12,600 families in Wales are affected by this condition. Even with those numbers, awareness of fluctuating conditions such as these is crucial in …..."
Nick Thomas-Symonds - View Speech

View all Nick Thomas-Symonds (Lab - Torfaen) contributions to the debate on: Appropriate ME Treatment
Written Question
Drugs: Innovation
Friday 18th January 2019

Asked by: Nick Thomas-Symonds (Labour - Torfaen)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether it is an objective of the new NHS Long Term Plan to ensure that the most innovative drugs will be accessible to patients more quickly than they currently are.

Answered by Steve Brine

The NHS Long Term Plan, together with other recent initiatives including the Life Sciences Sector Deal and the 2019 Voluntary Scheme for Branded Medicines Pricing, describe the Government’s objectives for a health and care system that delivers world leading patient care and health outcomes.

The Government wants patients to benefit from effective new drugs and the Voluntary Scheme for Branded Medicines Pricing and Access agreed between the Department and the branded pharmaceutical industry commits to align the speed of National Institute for Health and Care Excellence technology appraisals for non-cancer medicines to the faster timeline for cancer medicines.

In addition, the Life Sciences Industrial Strategy set out a vision of being a world-leader in developing and bringing to market innovative medicines to improve life-chances of United Kingdom patients. It highlighted the importance of evolving and simplifying the access system for new medicines by implementing, and building on, the findings of the Accelerated Access Review.

Speech in Westminster Hall - Wed 09 Jan 2019
Diabetes

"Will the right hon. Gentleman give way?..."
Nick Thomas-Symonds - View Speech

View all Nick Thomas-Symonds (Lab - Torfaen) contributions to the debate on: Diabetes
Speech in Westminster Hall - Wed 09 Jan 2019
Diabetes

"I thank the right hon. Gentleman for giving way and congratulate him on securing this debate. The statistic for Wales is that one person in 14 is affected. Does he agree that, going forward, we must look at prevention—seeing the warning signs and looking at lifestyle changes—as well as having …..."
Nick Thomas-Symonds - View Speech

View all Nick Thomas-Symonds (Lab - Torfaen) contributions to the debate on: Diabetes
Speech in Westminster Hall - Tue 08 Jan 2019
Cancer Workforce and Early Diagnosis

"I lost my mother to bowel cancer last year, and I have been campaigning to reduce the bowel cancer screening age to 50. I understand from my campaign and the debates I have had that it is important that we get the pathology capacity right. Otherwise the reduction in the …..."
Nick Thomas-Symonds - View Speech

View all Nick Thomas-Symonds (Lab - Torfaen) contributions to the debate on: Cancer Workforce and Early Diagnosis
Speech in Westminster Hall - Wed 21 Nov 2018
Nursing: Higher Education Investment

"I congratulate my hon. Friend on securing this important debate, and I commend what my hon. Friend the Member for Coventry South (Mr Cunningham) said about the proposition that we need to pay our nurses properly to value them truly. Does my hon. Friend the Member for Wolverhampton South West …..."
Nick Thomas-Symonds - View Speech

View all Nick Thomas-Symonds (Lab - Torfaen) contributions to the debate on: Nursing: Higher Education Investment
Speech in Westminster Hall - Tue 30 Oct 2018
Ovarian Cancer: Diagnosis and Treatment

"I warmly congratulate the hon. Gentleman on securing the debate. To improve survival rates, we need earlier diagnosis. For many years ovarian cancer was known as the silent killer, but there are a number of signs and symptoms. Will he join me in encouraging anyone with those signs and symptoms …..."
Nick Thomas-Symonds - View Speech

View all Nick Thomas-Symonds (Lab - Torfaen) contributions to the debate on: Ovarian Cancer: Diagnosis and Treatment
Speech in Commons Chamber - Mon 22 Oct 2018
Paediatric Cancers of the Central Nervous System

"I congratulate my hon. Friend on securing this debate, and on speaking so movingly about his young constituent. Having experienced having a seriously ill child, I know that one vital thing in such a situation is the care that hospitals provide not just for the child, but for the parents …..."
Nick Thomas-Symonds - View Speech

View all Nick Thomas-Symonds (Lab - Torfaen) contributions to the debate on: Paediatric Cancers of the Central Nervous System